Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 3, 2026 | Cat | Domestic Mediumhair | Praziquantel; Emodepside | Application site alopecia | Outcome Unknown |
| Mar 3, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Urinary tract infection; Elevated betahydroxybutyrate (BHBA); Discoloured urine | Outcome Unknown |
| Mar 3, 2026 | Cat | Domestic Longhair | Robenacoxib | Not drinking; Oliguria; Neutrophilia; Reluctant to move; Behavioural disorder... | Recovered/Normal |
| Mar 3, 2026 | Cat | Domestic Mediumhair | Praziquantel; Emodepside | Application site alopecia | Outcome Unknown |
| Mar 3, 2026 | Cat | Domestic Longhair | Maropitant Citrate | Generalised itching; Skin scab; Crust; Discomfort NOS; Reddening of the skin;... | Ongoing |
| Mar 2, 2026 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Behavioural disorder NOS; Lack of efficacy (endoparasite) - tapeworm; Applica... | Outcome Unknown |
| Mar 2, 2026 | Cat | Domestic Mediumhair | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 2, 2026 | Cat | American Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea | Outcome Unknown |
| Mar 2, 2026 | Cat | Cat (other) | Frunevetmab | Acute renal failure; Listless | Recovered/Normal |
| Mar 2, 2026 | Cat | Cat (unknown) | Buprenorphine | Hiding; Unclassifiable adverse event | Recovered/Normal |
| Mar 2, 2026 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site hair loss; Application site scab | Ongoing |
| Mar 1, 2026 | Cat | Scottish Fold Longhair, Cat... | Cefovecin | Lack of efficacy - NOS; Intentional misuse | Ongoing |
| Mar 1, 2026 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Elevated liver enzymes NOS; Abnormal cytology; Death by euthanasia; Elevated ... | Euthanized |
| Mar 1, 2026 | Cat | Domestic Shorthair | Cyclosporine | Polydipsia; Polyuria; Hyperglycaemia; Diabetes mellitus; UNPALATABLE; Product... | Ongoing |
| Mar 1, 2026 | Cat | Domestic Shorthair | Frunevetmab | Skin lesion NOS; Skin scab; Alopecia local | Ongoing |
| Mar 1, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea | Ongoing |
| Mar 1, 2026 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Mar 1, 2026 | Cat | Siamese | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 1, 2026 | Cat | Domestic Shorthair | Frunevetmab | Blindness; Walking difficulty; Difficulty to rise | Ongoing |
| Mar 1, 2026 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Hiding; Partial anorexia; Elevated cholesterol (total); Lipaemia; Elevated tr... | Ongoing |
| Mar 1, 2026 | Cat | Siamese | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 28, 2026 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 28, 2026 | Cat | American Shorthair | Fluralaner Spot-On Solution | Application site hair loss; Application site reddening; Application site irri... | Recovered/Normal |
| Feb 28, 2026 | Cat | Somali cat | Selamectin;Sarolaner | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Feb 27, 2026 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Feb 27, 2026 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Seizure NOS | Outcome Unknown |
| Feb 27, 2026 | Cat | American Shorthair | Selamectin;Sarolaner | Lack of efficacy (ectoparasite) - tick NOS | Outcome Unknown |
| Feb 27, 2026 | Cat | Domestic Shorthair | Frunevetmab | Diarrhoea; Decreased appetite; Lethargy (see also Central nervous system depr... | Recovered/Normal |
| Feb 27, 2026 | Cat | Domestic Shorthair | Robenacoxib | Lethargy (see also Central nervous system depression in Neurological); Hiding... | Recovered/Normal |
| Feb 26, 2026 | Cat | Persian | Selamectin;Sarolaner | Wobbliness; Seizure NOS; Other abnormal test result NOS | Ongoing |
| Feb 26, 2026 | Cat | Cat (unknown) | Bexagliflozin | Lack of efficacy - NOS | Outcome Unknown |
| Feb 26, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Elevated betahydroxybutyrate (BHBA); Elevated fructosamine | Outcome Unknown |
| Feb 26, 2026 | Cat | Domestic Shorthair | Milbemycin Oxime | Suckling disorder NOS; Licking; Skin scab; Peripheral vascular disorder; Pinn... | Outcome Unknown |
| Feb 26, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Hyperglycaemia; Elevated betahydroxybutyrate (BHBA) | Ongoing |
| Feb 26, 2026 | Cat | Domestic Shorthair | Thiamazole | Facial swelling (see also Skin) | Recovered/Normal |
| Feb 25, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; Polyuria; Hypothyroidism; Azotaemia; Polydipsia; Hyperphosphataemi... | Ongoing |
| Feb 25, 2026 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Feb 24, 2026 | Cat | Domestic Shorthair | Protamine Zinc Recombinant Human Insulin | INEFFECTIVE, GLYCEMIC CONTROL; INEFFECTIVE, LOSS OF EFFECT | Outcome Unknown |
| Feb 24, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 24, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 24, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 24, 2026 | Cat | Domestic Shorthair | Frunevetmab | Skin lesion NOS; Pinnal ulcer | Recovered/Normal |
| Feb 24, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 24, 2026 | Cat | Domestic Longhair | Mirtazapine | Application site scab; Vomiting; Application site skin change NOS | Outcome Unknown |
| Feb 23, 2026 | Cat | American Curl Shorthair | Frunevetmab | Hind limb paralysis | Outcome Unknown |
| Feb 23, 2026 | Cat | Siamese | Frunevetmab | Skin sore; Localised itching | Ongoing |
| Feb 22, 2026 | Cat | Siamese, Cat (unknown) | Isoflurane | Not eating; Hyperthermia; Urinary retention; Intestinal stasis; Hypoalbuminae... | Ongoing |
| Feb 21, 2026 | Cat | Domestic Mediumhair | Frunevetmab | Hind limb paralysis; Musculoskeletal disorder NOS; Urinary incontinence; Prop... | Ongoing |
| Feb 21, 2026 | Cat | Domestic Shorthair | Buprenorphine | Hyperactivity; Urinary retention; Constipation; Restlessness; Dysphoria; Not ... | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.